Covid-19 breath test startup Breathonix raising US$5m capital
Singapore
BREATHONIX, a Singapore-based startup which has gotten provisional authorisation locally for its Covid-19 breath test, is raising US$5 million in Series A funding to fuel its growth.
"At this stage now, we are growing very fast. We're expanding our team for commercialisation, so we're actively raising more funds," co-founder and chief operating officer Du Fang said during a Monday virtual press conference.
TRENDING NOW
Yeoh Pei Xien: YTL’s third-gen scion with a pastor’s heart
UOB CEO’s youngest child Grant Wee turns burnout into a wellness business
Keppel H1 net profit drops 59% to S$155 million on impairments, M1 deal fallout; shares fall 4%
Singtel explores Nasdaq-SGX dual listing for data centre arm Nxera, local data centre Reit